baber/WOPTO huggingface dataset:
Patent NZ-573178-A (NZ)
Title: Methods and compositions for targeting hepsin
Inventor: KIRCHHOFER DANIEL K
IPC: G01N33/53
Filed: 2007-06-20
Abstract: Disclosed are isolated antibodies that bind outside an active site of human hepsin that is bound by an endogenous inhibitor. Also disclosed are nucleotide sequences encoding the antibodies and cell lines capable of producing the antibodies. The antibodies are used in methods including determining the presence of cells associated with dysregulation of hepsin expression in a subject, predicting responsiveness of a subject to therapy for a disease associated with dysregulation of hepsin expression, assessing minimal residual disease in a subject treated for a disease associated with dysregulation of hepsin expression, detecting a disease state associated with dysregulation of hepsin expression, assessing predisposition of a subject to develop a disorder associated with dysregulation of hepsin expression and for diagnosing a disorder associated with dysregulation of hepsin expression.
Patent NZ-577101-A (NZ)
Title: Controlling kites using a separate motor for differential control action
Inventor: MILANESE MARIO
IPC: B63B35/79
Filed: 2007-11-30
Abstract: Disclosed is a system (10 for performing the automatic control of the flight of at least one kite (11) controlled and driven by cables (13). The system comprises at least one first actuating motor (12) adapted to exert an unwinding-rewinding action of such cables on respective winches (14a, 14b), and at least one second actuating motor (15) adapted to perform a differential control action of such cables.
Patent NZ-583191-A (NZ)
Title: 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the treatment of post-traumatic stress disorder
Inventor: WOIWODE TOM
IPC: A01N43/40
Filed: 2008-07-23
Abstract: The use of a therapeutically effective amount of 4-hydroxy-4-methylpiperidine-l-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide in the manufacture of a medicament for treating post-traumatic stress disorder.
Patent NZ-591981-A (NZ)
Title: Glucuronidated acetaminophen as a marker of hepatic disorders
Inventor: CHERRINGTON NATHAN
IPC: G01N33/94
Filed: 2009-09-30
Abstract: NZ 591981 Disclosed is a method for diagnosing a hepatic disorder in a human, comprising: determining an amount of acetaminophen (APAP)-glucuronide in a plasma sample and/or a urine sample obtained from a human subject after the human subject was administered APAP, wherein the human subject is at risk of a hepatic disorder; comparing the amount of APAP-glucuronide in one or both of the plasma sample and the urine sample to a control; and identifying the human subject as having a hepatic disorder if the amount of APAP-glucuronide in one or both of the plasma sample and the urine sample is elevated relative to the control.
Patent NZ-594491-A (NZ)
Title: Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
Inventor: CARRERA CARRERA FRANCESC
IPC: A61K31/44
Filed: 2010-03-11
Abstract: 594491 Disclosed herein is a crystalline addition salt of tromethamine with an azabiphenylaminobenzoic acid derivative of formula (I), wherein the variables are defined in the specification; a pharmaceutical composition comprising said salt and one or more other therapeutic agents selected from anti-TNF-alpha monoclonal antibodies, TNF-alpha antagonists, calcineurin (PP-2B) inhibitors/INS expression Inhibitors, IL-1 receptor antagonists, Anti-CD20 monoclonal antibodies, p38 Inhibitors, NF-kappaB (NFKB) activation Inhibitors, dihydrofolate reductase (DHFR) Inhibitors, JAK3 Inhibitors, MEK inhibitors, S1 P1 agonists, interferons, inmunomodulators, and UD adenosine aminohydrolase inhibitors; and the use of said pharmaceutical composition in the treatment of a pathological condition or disease susceptible to amelioration by inhibition of dihydroorotate dehydrogenage such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondilytis, multiple sclerosis, Wegener's granulomatosis, systemic lupus erythematosus, psoriasis and sarcoidosis.
Patent NZ-595110-A (NZ)
Title: Use of atorvastatin lactols as medicaments
Inventor: LINDSAY DEREK
IPC: A61K31/40
Filed: 2010-03-10
Abstract: 595110 Disclosed herein is the use of a compound of Formula I, wherein the variable are defined in the specification, for the treatment of a condition treatable by the inhibition of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) wherein the considition is selected from the group consisting of hypercholesterolemia, atherosclerosis, hyperlipidemia, cardiovascular disease, coronary heart disease, myocardial infarction, stroke, peripheral artery disease, inflammation, dementia, cancer, nuclear cataracts, diabetes and hypertension.
Patent NZ-596978-A (NZ)
Title: Fluorinated ketones as a high-voltage insutlating medium
Inventor: GLASSMACHER PETER
IPC: H02B13/055
Filed: 2010-06-14
Abstract: Disclosed is a switching device (200) for medium, high, or extremely high voltage, wherein at least one voltaged component (100, 202, 203, 400) of the switching device is enclosed in an enclosure (201, 206) which is filled with a filling medium (204), wherein the filling medium (204) is an electrical insulation medium which comprises: (a) a fluorinated ketone from the group of fluorinated ketones C4-C8 with the general formula R-C(0)-R’, wherein R and R’ are partially fluorinated or perfluorinated substituents, or (b) a fluorinated ketone from the group of fluorinated ketones C5-C7, C9, C10, C11, C13, C14 and C15.
Patent NZ-601980-A (NZ)
Title: Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
Inventor: ROSANDER ANNA
IPC: A61K39/02
Filed: 2011-01-28
Abstract: Disclosed is an isolated protein having the amino acid sequence according to SEQ ID NO: 4 or SEQ ID NO: 6, or an active fragment or derivative thereof capable of inducing an immune response to said protein, or an active fragment or derivative capable of binding to an antibody produced by a subject in an immune response against said protein, wherein the sequences are as defined in the complete specification. Also disclosed is the use of an isolated protein having the amino acid sequence according to SEQ ID NO: 4 or SEQ ID NO: 6, or an active fragment or derivative thereof capable of inducing an immune response to said protein, or an active fragment or derivative capable of binding to an antibody produced by a subject in an immune response against said protein, in the manufacture of a medicament for the treatment or prevention of a disease caused by Treponema spp.
Patent NZ-614135-A (NZ)
Title: Improvements in and relating to sweeping implements
Inventor: SIMON LOWE
IPC: A46B15/00
Filed: 2013-05-28
Abstract: 614135 A sweeping implement is disclosed, typically as a wool sweep, with handle as removable upper connected to lower portion, with lower portion having a head that is pivoted about an axis perpendicular to the handle longitudinal axis.
Patent NZ-614218-A (NZ)
Title: Dispiropyrrolidine derivatives
Inventor: WAKABAYASHI TAKANORI
IPC: C07D519/00
Filed: 2012-03-09
Abstract: Disclosed is a family of dispiropyrrolidine derivative compounds of formula (1), wherein A, B, R1, R2 and R3 are as defined in the specification. The disclosure also relates to these compound’s use to inhibit interaction between Mdm2 (murine double minute 2) protein and p53 protein and to slow cancer tumors. Examples compounds include: (3’R,4’S,5’R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6”-chloro-4’-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2”-oxo-1”,2”-dihydrodispiro[cyclohexane-1,2’-pyrrolidine-3’,3”-indole]-5’-carboxamide sulfate. (3’R,4’S,5’R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6”-chloro-4’-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2”-oxo-1”,2”-dihydrodispiro[cyclohexane-1,2’-pyrrolidine-3’,3”-indole]-5’-carboxamide methanesulfonate. (3’R,4’S,5’R)-N-[(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]-6”-chloro-4’-(2-chloro-3-fluoropyridin-4-yl)-4,4-dimethyl-2”-oxo-1”,2”-dihydrodispiro[cyclohexane-1,2’-pyrrolidine-3’,3”-indole]-5’-carboxamide ethanesulfonate.
Patent NZ-624635-A (NZ)
Title: Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators
Inventor: DONELLO JOHN E
IPC: C07C275/28
Filed: 2012-10-23
Abstract: Disclosed are N-urea amide derivative compounds of formula (II), wherein the substituents as defined in the specification. Also disclosed is the use a compound of formula (II) as a modulator of the N-formyl peptide receptor like-1 (FPRL-1) receptor for treating ocular inflammatory diseases. An example of a compound of formula (II) is: (2S,3S)-N-(2-amino-2-oxoethyl)-2-{ [(4-bromophenyl) carbamoyl]amino} -3-methylpentanamide
Patent NZ-625428-A (NZ)
Title: Dehydrogenation of alkanols to increase yield of aromatics
Inventor: BLOMMEL PAUL G
IPC: C07C45/39
Filed: 2011-11-29
Abstract: The present disclosure provides methods, reactor systems, and catalysts for increasing the yield of aromatic hydrocarbons produced while converting alkanols to hydrocarbons. The disclosure includes methods of using catalysts to increase the yield of benzene, toluene, and mixed xylenes in the hydrocarbon product. The process proceeds by partially dehydrogenating an alkanol feedstock in the presence of a dehydrogenation catalyst at a temperature and pressure sufficient to produce hydrogen and a mixture of oxygenate components comprising unreacted alkanol and carboxylic acids, aldehydes and esters; wherein at least a portion of the oxygenate components in the mixture have a hydrogen to carbon effective ratio of less than 1.6 and wherein the extent of partial dehydrogenation results in the mixture of oxygenate components having a total hydrogen to carbon effective ratio of between 1.2 and 1.8; and exposing the oxygenate component to an oxygenate conversion catalyst at an temperature and pressure sufficient to produce aromatic hydrocarbons.
Patent NZ-705247-A (NZ)
Title: Particle-coded container
Inventor: BRYANT JESSICA ROSE
IPC: C03C17/04
Filed: 2013-10-03
Abstract: A method of marking or coding containers including applying particles to the containers so that the particles bond with the containers to form unique optically readable patterns. The optically readable patterns provide the containers with attractive markers that can be used for tracking, anti-counterfeiting, or other purposes. Unlike bar code labels or spray paint, the optically readable patterns cannot be removed from the containers without damaging the containers or otherwise compromising the structural and/or functional integrity of the containers, and thus are resistant to tampering.
Patent NZ-710017-A (NZ)
Title: Animal identification system including a male portion, female portion, and removable device for storing a sample
Inventor: TEYCHENE BRUNO
IPC: A61B10/02
Filed: 2014-02-06
Abstract: A system for identifying an animal comprising a male part, a female part and a detachable device for storing a sample. Problems solved by the invention may include enabling an identification tag to be placed simultaneously with the collecting of a sample of tissue whilst maintaining inviolability of the tag. The invention pertains to a system for identifying an animal comprising a male part, cooperating with at least one cutting element intended to cut out a sample of animal tissue, a female part with open head having a through-channel, and a detachable device for storing said sample, intended to be fixed to one end of said through-channel. According to the invention, the system also comprises means for closing said head that can take at least two positions, comprising an open position enabling the passage of said sample through the through-channel during a collecting operation, and an irreversible closed position by which the channel is closed in the vicinity of said one end subsequently to the collecting operation.
Patent NZ-712728-A (NZ)
Title: Method and device for the testing of fire extinguishing systems
Inventor: BUITENHUIS ANTOON LAMBERTUS RUURD
IPC: A62C37/50
Filed: 2014-02-26
Abstract: An installation and method disclosed generally addresses the disadvantages of complex, costly and harmful installations and methods for the testing of open fire extinguishing systems. The installation, suitable for the testing of open, deluge fire extinguishing systems, comprises a smoke and/or mist generator and a connecting conduit, suitable and dedicated for connecting the smoke and/or mist generator to an open fire extinguishing system; wherein the generator comprises a compressor and/or a pump which is able to generate a gas flow of at least 18 litres per second and/or is able to generate a pressure drop of at least 0.2 bars and/or which is able to generate a smoke to be generated with an optical smoke density of at least 10 per meter.
Patent NZ-732088-A (NZ)
Title: A roofing, cladding or siding product
Inventor: BUCKINGHAM SAMUEL GWYNN
IPC: B29C48/12
Filed: 2015-12-01
Abstract: This invention relates to a roofing, cladding, or siding module 1, comprising an underlapping region 2 extending from a head edge 4 of the module 1 and an exposed region 3 extending from a foot edge 5 of the module 1. The length of the foot edge 5 defining the length of the module 1. The underlapping region 2 is adapted to be substantially covered by the exposed region of an adjacent or overlapping module when installed on a building surface. The module is formed of at least one layer of extruded material. The layer so formed comprises at least 40% w/w filler and/or reinforcement, and one or more polymer(s). The reinforcement comprises one or more non-conductive natural or synthetic fibres. The layer comprises at least 6% w/w of the one or more non-conductive natural or synthetic fibres, and the fibres are aligned along the length of the module. The module comprises a plurality of formed surfaces molded along the length of the module, each of the formed surfaces comprising at least one three-dimensional surface feature. The module is capable of being industrially produced in suitable quantities.
Patent NZ-733889-A (NZ)
Title: Method of manufacturing stereoisomers of buprenorphine and analogues thereof
Inventor: SAHLI STEFAN
IPC: C07D489/09
Filed: 2016-03-11
Abstract: The present invention relates to a method of preparing a compound of Formula II-a’ or Formula II-b’, wherein RI represents hydrogen or a linear, branched and/or cyclic alkyl or alkenyl group having 1 to 10 carbon atoms; RII represents a linear, branched and/or cyclic alkyl or alkenyl group having 1 to 10 carbon atoms; RIII represents hydrogen or a linear, branched and/or cyclic alkyl or alkenyl group having 1 to 10 carbon atoms or a linear, branched and/or cyclic alkoxy group having 1 to 10 carbon atoms; RIV represents hydrogen or a linear, branched and/or cyclic alkyl group having 1 to 10 carbon atoms or an optionally substituted aryl or alkylaryl group having 6 to 40 carbon atom or acetyl or silyl or a protective group; and RV represents hydrogen or a methyl group; wherein RI and RII are different from each other.
Patent NZ-742123-A (NZ)
Title: Strap locating arrangement
Inventor: ABOOD RALPH JUSTIN
IPC: B60P7/08
Filed: 2016-10-28
Abstract: The present invention relates to a strap locating arrangement, configured for allowing drivers of large vehicles to locate strapping over especially high loads on a vehicle load bed or to locate strapping through gaps between the top of their loads and the bottom of the vehicle roof, including a channel receiving arrangement configured for receiving at least part of a rolled up load securing strap; the channel receiving arrangement being made up of an elongate and straight base wall and parallel side walls; the channel receiving arrangement including a slot through which an un-rolled portion of the load securing strap is extendable in a direction extending tangentially outward from the rolled up strap; the receiving arrangement being attachable to an elongate extension member.
Patent NZ-782442-A (NZ)
Title: Antibodies that bind cd39 and uses thereof
Inventor: PRINZ BIANKA
IPC: A61P35/02
Filed: 2019-03-13
Abstract: The present disclosure relates to anti-CD39 antibodies, and antigen binding portions thereof and their use in treating cancer.
Patent PT-100797-A (PT)
Inventor: BABIN JAMES EDWARD
IPC: B01J/
Filed: 1992-08-20
Abstract: This invention relates to asymmetric syntheses in which a prochiral or chiral compound is contacted in the presence of an optically active metal-ligand complex catalyst to produce an optically active product.
Patent PT-101825-A (PT)
Title: Suspension flow type reactor
Inventor: GULYURTLU I
IPC: C10B53/00
Filed: 1996-02-06
Abstract: This invention relates to a reactor of the suspension flow type and is intended for the processing of plastics wastes by the pyrolysis process. It comprises a reactor 1 which essentially comprises a sealed cylindrical body 16; a tubular heat exchanger 2, a gas combustion chamber 3, an ignition system for start-up 14, a blower system for gas circulation 12; storage silos and a corresponding feed system (9 and 8), a system for the extraction of liquids 17, a compressor 13, a system for the cleaning of gases and the removal of chlorine, a system for the automatic control of reactor operation and remaining equipment 10 and gas turbine 11. <IMAGE>
Patent PT-104252-A (PT)
Title: Método para compressão da composição do léxico com o modelo de língua num sistema de reconhecimento de fala para dispositivos móveis
Inventor: MIRANDA JOAO TIAGO RODRIGUES DE SOUSA
IPC: G06F40/00
Filed: 2008-11-06
Abstract: A PRESENTE PATENTE APRESENTA UM MÉTODO DE COMPRESSÃO DA COMPOSIÇÃO DE UM LÉXICO COM UM MODELO DE LÍNGUA NO ÂMBITO DE UM SISTEMA DE DESCODIFICAÇÃO DE UM SISTEMA DE RECONHECIMENTO DE FALA. ESTE MÉTODO PODE SER REALIZADO NUMA GRANDE VARIEDADE DE DISPOSITIVOS, PERMITINDO A EXECUÇÃO DE TAREFAS DE RECONHECIMENTO DE MÉDIA DIMENSÃO EM DISPOSITIVOS COM REDUZIDOS RECURSOS COMPUTACIONAIS, E FACILITANDO A PARALELIZAÇÃO DE TAREFAS COM VOCABULÁRIOS MUITO LARGOS EM MÁQUINAS DE MAIORES RECURSOS COMPUTACIONAIS. O MÉTODO AQUI DESCRITO COMPREENDE ESSENCIALMENTE DOIS PONTOS PRINCIPAIS: A COMPRESSÃO EM TEMPO DE EXECUÇÃO DA COMPOSIÇÃO DO LÉXICO COM O MODELO DE LÍNGUA UTILIZANDO CAMINHOS LINEARES E UMA CODIFICAÇÃO DE TAMANHO VARIÁVEL DOS CAMPOS DOS ARCOS DO MODELO, E O DESENHO DE UMA ESTRUTURA DE DADOS (CACHE) PARA FACILITAR O ACESSO AO TRANSDUTOR COMPRIMIDO, CRIADA DE FORMA A EXPLORAR AS PARTICULARIDADES DO AUTÓMATO (CAMINHOS LINEARES) UTILIZADAS NO PASSO ANTERIOR.
Patent PT-109287-A (PT)
Title: Sistema para a preparação de água quente e processo para a operação de um sistema para a preparação de água quente.
Inventor: PEDRO PINTO
IPC: G05D23/00
Filed: 2016-04-01
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UM SISTEMA PARA A PREPARAÇÃO DE ÁGUA QUENTE (10A), PARTICULARMENTE PARA A PREPARAÇÃO DE ÁGUA POTÁVEL, QUE COMPREENDE PELO MENOS UMA UNIDADE DE REGULAÇÃO DE TEMPERATURA (12A), QUE ESTÁ PREVISTA PARA REGULAR UMA TEMPERATURA DA ÁGUA EM PELO MENOS UM PONTO DE EXTRAÇÃO DE ÁGUA (16A).É SUGERIDO QUE A UNIDADE DE REGULAÇÃO DE TEMPERATURA (12A) ESTEJA PREVISTA PARA COMUNICAR COM PELO MENOS UMA UNIDADE DE AQUECIMENTO (22A) PARA A REGULAÇÃO DA TEMPERATURA DA ÁGUA NO PONTO DE EXTRAÇÃO DE ÁGUA (16A).
Patent RU-94015307-A (RU)
Inventor: PAPULOV L M
IPC: A61G10/02
Filed: 1994-04-25
Abstract: FIELD: medicine. SUBSTANCE: method of creation of medicinal air atmosphere of underground space on surface is realized by usage of natural salts and minerals placed in surface structures and by ventilation to remove spent air which is periodically switched on when air is polluted. EFFECT: enhanced efficiency of method.
Patent RU-94021312-A (RU)
Inventor: RYS EV O A
IPC: A61K35/08
Filed: 1994-07-01
Abstract: FIELD: physiotherapy, water cure in particular. SUBSTANCE: method provides, that crushed mineral schungite with fractions size of 5 - 20 mm is poured with drinking water in ratio of 1 : 1 by volume and held them for 2 - 3 days under room temperature and then infusion is discharged. EFFECT: method allows to prepare artificial mineralized water for outside usage during relatively short time.
Patent RU-94024866-A (RU)
Inventor: AGROSKIN B N
IPC: G01C19/24
Filed: 1994-07-01
Abstract: FIELD: gyroscopy and navigation technique; manufacture of electrostatic gyroscopes. SUBSTANCE: sensitive element has ceramic vacuum chamber consisting of two hemispheres and connected at centering ring; rotor with contrast raster on its surface is located inside this chamber. Chamber is provided with six optical windows; one at pole of each hemisphere and four windows in centering ring. Optical windows are connected through current-conducting composition whose layer embraces each window in form of rings located on either end surface of each window. Applied on inner surfaces of hemispheres in form of metal film are electrodes whose parts are brought out to recesses in parting plane. Located inside vacuum volume of chamber in zone of optical windows are six metal diaphragms; four diaphragms are located in equatorial plane of chamber ring and two other diaphragms are located at poles of hemispheres. Entrance pupils of diaphragms are closely brought to surface of rotor and axes of their holes form orthogonal optical trihedral whose center coincides with center of electrodes of rotor gimbal. Diaphragms are located on circular current-carrying layers of chamber and flexible members, in form of springs, for example, are fitted on them; flexible members are engageable with parts of electrodes of hemispheres. Electrostatic gyroscope may be used in gimballess version of gyroscope. Used as sealed leads of electrodes are current-carrying members of optical channels. EFFECT: enhanced accuracy and reliability.
Patent RU-94025091-A (RU)
Title: Bioenergetic complex
Inventor: KONJAEV M V
IPC: C02F11/04
Filed: 1994-07-04
Abstract: FIELD: anaerobic fermentation of organic mass, for instance, manure, food wastes; applicable in agriculture and other fields. SUBSTANCE: bioenergetic complex has reactor reservoir, units for grinding, loading, heating, mixing, unloading; device for storage and accumulation of sewage gas. Heating unit is located on the upper part of reactor reservoir and communicated with bottom part of reactor space through loading pipeline with valve. Unloading unit is made in form of U-shaped gate. Reactor and heating unit have tubular heat-exchangers located horizontally over circumference in zones of filling with biological mass and their external surfaces are heat-insulated. Immobilizers are installed inside the reactor. EFFECT: higher efficiency.